Estudo randomizado | Lebriquizumabe combinado com corticosteroides tópicos em adolescentes e adultos com dermatite atópica moderada a grave
16 Jan, 2023 | 10:48h
Comentário no Twitter
Does blocking the IL-13 cytokine w/ lebrikizumab combined w/ topical therapy provide clinical benefit in atopic eczema? This study reflecting real-world use patterns suggests a benefit. https://t.co/apUvYO3Jqv
— JAMA Dermatology (@JAMADerm) January 13, 2023